CAL101 is a first-in-class monoclonal antibody targeting S100A4, a damage-associated molecular pattern (DAMP) protein associated with serious and life-threatening fibrotic disordersPhase 2 AURORA ...

Regulatory News:Celyad Oncology (Euronext: CYAD) (“Celyad” or the “Company”), today announced that it has decided to discontinue its research and development (R&D) activities and to implement a ...

The Microcatheters Market is undergoing rapid expansion, fuelled by the growing adoption of minimally invasive procedures, ...

In digital world, investing has become easier and smarter thanks to AI-powered apps. Wealthfront is one of the most popular ...

DNA Methylation Market OverviewDNA methylation is a biological process in which methyl groups (CH3) are added to the DNA ...

Spinal Implants Material Market OverviewThe global Spinal Implants Material Market is valued at USD 9.8 Million in 2024 and ...

Royalty Pharma will pay up to $950 million for a 7 percent royalty in Amgen’s Imdelltra, a breakthrough small cell lung ...

The global neonatal intensive care respiratory devices market is expected to grow at a CAGR of ~6% during the forecast period ...

The global ventricular assist devices (VAD) market is projected to grow at a CAGR of ~11% during the forecast period. This growth is primarily driven by the rising prevalence of heart failure, the ...

Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, announces the completion of the first cohort in the clinical Phase I trial evaluating the drug candidate ...

Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced that Snapdragon Chemistry, a Cambrex company, has expanded its active pharmaceutical ingredient ...

The global atherectomy devices market is expected to grow at a CAGR of ~8% during the forecast period. The increasing ...